Abstract
The influence of quinolones on electrically evoked pyramidal cell activity in the rat hippocampus in vitro was studied by using the slice technique. We hoped to learn more about the possible mechanisms for the development of side effects of different quinolones and to find a possible treatment. As reported earlier (W. Dimpfel, M. Spüler, A. Dalhoff, W. Hofmann, and G. Schlüter, Antimicrob. Agents Chemother. 35:1142-1146, 1991), the amplitude of the population spike increased in the presence of ciprofloxacin, lomefloxacin, or ofloxacin about twofold in comparison with reference values. This increase could be prevented in a concentration-dependent manner by the concomitant presence of 3-amino-1-hydroxy-2-pyrrolidone (HA 966), a compound acting at the so-called glycine site of the N-methyl-D-aspartate (NMDA) receptor, but not in the presence of aminophosphonovaleric acid (APV), which acts at a different recognition site of the NMDA receptor. Another tool, 6,7-dinitroquinoxaline-2,3-dione, an antagonist of the so-called AMPA receptor (named after the binding of L-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid [AMPA] to this site), could not antagonize the effect induced by the quinolones. Activation of the glycine site of the NMDA receptor induced by the presence of D-serine in the superfusion medium also resulted in a concentration-dependent increase in the population spike amplitude. This response remained unchanged in the presence of ciprofloxacin, whereas lomefloxacin and ofloxacin led to further increases in the amplitude, especially in the presence of higher concentrations of D-serine. These results also point to an involvement of the glycine site of the central NMDA receptor in the development of side effects by different quinolones. A complete attenuation of the quinolone-induced effects was obtained in the presence of 2.5 microM gamma-hydroxybutyric acid (GHB), a physiological neuromodulator which is marketed in some countries of Europe as a sedative. It is therefore concluded that the excitatory adverse effects of quinolones might be treated by the administration of GHB.
Full Text
The Full Text of this article is available as a PDF (293.0 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Cash C. D. Gamma-hydroxybutyrate: an overview of the pros and cons for it being a neurotransmitter and/or a useful therapeutic agent. Neurosci Biobehav Rev. 1994 Summer;18(2):291–304. doi: 10.1016/0149-7634(94)90031-0. [DOI] [PubMed] [Google Scholar]
- Dimpfel W., Dalhoff A., Hofmann W., Schlüter G. Electrically evoked potentials in the rat hippocampus slice in the presence of aminophylline alone and in combination with quinolones. Eur Neuropsychopharmacol. 1994 Jun;4(2):151–156. doi: 10.1016/0924-977x(94)90009-4. [DOI] [PubMed] [Google Scholar]
- Dimpfel W., Spüler M., Dalhoff A., Hofmann W., Schlüter G. Hippocampal activity in the presence of quinolones and fenbufen in vitro. Antimicrob Agents Chemother. 1991 Jun;35(6):1142–1146. doi: 10.1128/aac.35.6.1142. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dodd P. R., Davies L. P., Watson W. E., Nielsen B., Dyer J. A., Wong L. S., Johnston G. A. Neurochemical studies on quinolone antibiotics: effects on glutamate, GABA and adenosine systems in mammalian CNS. Pharmacol Toxicol. 1989 May;64(5):404–411. doi: 10.1111/j.1600-0773.1989.tb00676.x. [DOI] [PubMed] [Google Scholar]
- Haas H. L., Schaerer B., Vosmansky M. A simple perfusion chamber for the study of nervous tissue slices in vitro. J Neurosci Methods. 1979 Dec;1(4):323–325. doi: 10.1016/0165-0270(79)90021-9. [DOI] [PubMed] [Google Scholar]
- Halliwell R. F., Davey P. G., Lambert J. J. Antagonism of GABAA receptors by 4-quinolones. J Antimicrob Chemother. 1993 Apr;31(4):457–462. doi: 10.1093/jac/31.4.457. [DOI] [PubMed] [Google Scholar]
- Halliwell R. F., Davey P. G., Lambert J. J. The effects of quinolones and NSAIDs upon GABA-evoked currents recorded from rat dorsal root ganglion neurones. J Antimicrob Chemother. 1991 Feb;27(2):209–218. doi: 10.1093/jac/27.2.209. [DOI] [PubMed] [Google Scholar]
- Johnson J. W., Ascher P. Glycine potentiates the NMDA response in cultured mouse brain neurons. Nature. 1987 Feb 5;325(6104):529–531. doi: 10.1038/325529a0. [DOI] [PubMed] [Google Scholar]
- Segev S., Rehavi M., Rubinstein E. Quinolones, theophylline, and diclofenac interactions with the gamma-aminobutyric acid receptor. Antimicrob Agents Chemother. 1988 Nov;32(11):1624–1626. doi: 10.1128/aac.32.11.1624. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tsuji A., Sato H., Kume Y., Tamai I., Okezaki E., Nagata O., Kato H. Inhibitory effects of quinolone antibacterial agents on gamma-aminobutyric acid binding to receptor sites in rat brain membranes. Antimicrob Agents Chemother. 1988 Feb;32(2):190–194. doi: 10.1128/aac.32.2.190. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Vayer P., Mandel P., Maitre M. Gamma-hydroxybutyrate, a possible neurotransmitter. Life Sci. 1987 Sep 28;41(13):1547–1557. doi: 10.1016/0024-3205(87)90721-1. [DOI] [PubMed] [Google Scholar]
- Yamamoto C., McIlwain H. Electrical activities in thin sections from the mammalian brain maintained in chemically-defined media in vitro. J Neurochem. 1966 Dec;13(12):1333–1343. doi: 10.1111/j.1471-4159.1966.tb04296.x. [DOI] [PubMed] [Google Scholar]